Oncolytics Biotech Inc. - Common Stock (NQ:ONCY)
Price and Volume
Detailed Quote| Volume | 445,104 |
| Open | 0.4000 |
| Bid (Size) | 0.3840 (2,100) |
| Ask (Size) | 0.3848 (500) |
| Prev. Close | 0.4000 |
| Today's Range | 0.3817 - 0.4072 |
| 52wk Range | 0.3940 - 1.300 |
| Shares Outstanding | 46,166,980 |
| Dividend Yield | N/A |
Top News
More News
Performance
52-Week Range
70.4% below 52-week high
0.3844
0.3952W Low
1.3052W High
1 Week
23.1% below 1-week high
0.391W Low
0.501W High
Oncolytics Biotech Inc. - Common Stock (ONCY) traded between $0.39 and $1.30 over the past 52 weeks and last traded at $0.38, 70.4% below its 52-week high. Over the past week it ranged between $0.39 and $0.50.
Past 12 Months
-16.9%
-35.6%
-50.4%
-58.6%
-60.9%
-64.7%
1W
-$0.08
1M
-$0.21
3M
-$0.39
6M
-$0.54
YTD
-$0.60
1Y
-$0.71
ONCY was -64.7% over the past year, -58.6% over six months, -60.9% year to date, -16.9% in the last week.
12 Months vs Market
ONCY
-64.7%
DIA
+9.2%
SPY
+10.3%
QQQ
+8.3%
IWM
+14.1%
Over the past 12 months ONCY returned -64.7% versus DIA (Dow) +9.2%, SPY (S&P 500) +10.3%, QQQ (Nasdaq 100) +8.3% and IWM (Russell 2000) +14.1%.
Volume & Liquidity
0.43× 3-mo avg
Today 445,104
3-mo avg 1.0M
1W
1.1M
1M
1.4M
3M
1.0M
6M
1.2M
YTD
1.3M
1Y
1.2M
ONCY most recently traded 445,104 shares against a 3-month average daily volume of 1.0M.
More News
Read More
From Equity Insider
Via GlobeNewswire
Registration Momentum Builds Across the Oncology Pipeline
February 17, 2026
From USA News Group
Via GlobeNewswire
The $71 Billion Cancer Shift: Why The FDA Is Speeding Up
February 05, 2026
From Equity Insider
Via GlobeNewswire
ONCY Stock Rallies On Second Fast Track Designation For Experimental Cancer Drug ↗
February 04, 2026
Via Stocktwits
THE RESILIENCE DOCTRINE: 5 Assets Securing the 2026 Sovereign Stack
January 26, 2026
From Equity Insider
Via GlobeNewswire
Top movers in Tuesday's after hours session ↗
January 20, 2026
Via Chartmill
THE SOVEREIGN MANDATE: 5 Stocks Securing the 2026 Choke Points
January 14, 2026
From USA News Group
Via GlobeNewswire
From Equity Insider
Via GlobeNewswire
From Equity Insider
Via GlobeNewswire
THE CHOKE POINT: 5 Assets That Control the Bottleneck
January 07, 2026
From Equity Insider
Via GlobeNewswire
Cancer Drug Developers Secure Regulatory Clarity as FDA Reshapes Approval Standards
December 16, 2025
From Equity Insider
Via GlobeNewswire
THE VISIBILITY INDEX: 5 Companies Solving the Invisible Crisis
December 15, 2025
From USA News Group
Via GlobeNewswire
GI Cancer Immunotherapy Breakthroughs Signal New Treatment Era
December 12, 2025
From Equity Insider
Via GlobeNewswire
THE EFFICIENCY PARADOX: 5 Market Anomalies Trading Below Reality
December 06, 2025
From USA News Group
Via GlobeNewswire
From USA News Group
Via GlobeNewswire
Frequently Asked Questions
Is Oncolytics Biotech Inc. - Common Stock publicly traded?
Yes, Oncolytics Biotech Inc. - Common Stock is publicly traded.
What exchange does Oncolytics Biotech Inc. - Common Stock trade on?
Oncolytics Biotech Inc. - Common Stock trades on the Nasdaq Stock Market
What is the ticker symbol for Oncolytics Biotech Inc. - Common Stock?
The ticker symbol for Oncolytics Biotech Inc. - Common Stock is ONCY on the Nasdaq Stock Market
What is the current price of Oncolytics Biotech Inc. - Common Stock?
The current price of Oncolytics Biotech Inc. - Common Stock is 0.3844
When was Oncolytics Biotech Inc. - Common Stock last traded?
The last trade of Oncolytics Biotech Inc. - Common Stock was at 11/03/26 03:03 PM ET
What is the market capitalization of Oncolytics Biotech Inc. - Common Stock?
The market capitalization of Oncolytics Biotech Inc. - Common Stock is 17.75M
How many shares of Oncolytics Biotech Inc. - Common Stock are outstanding?
Oncolytics Biotech Inc. - Common Stock has 18M shares outstanding.
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.
>